ZYME
ZYME
NASDAQ · Biotechnology

Zymeworks Inc

$26.81
+0.24 (+0.90%)
As of Sep 21, 10:01 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -33.4% upside
Low Target $12.55
Average Target $17.86
High Target $20.90
Current Price $26.81
Current
$26.81
Target
$17.86
$12.55 $17.86 avg $20.90
Scenario Analysis
Bear Case
$12.55
-53.2%
Low target
Base Case
$17.86
-33.4%
Avg target
Bull Case
$20.90
+-22.0%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$31.34
-14.5% from high
52-Week Low
$15.79
+69.8% from low
Target vs 52W High
$17.86
-43.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -17.9%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.2%